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Abstract
The aim of this study was to determine the as-
sociation between levels of physical activity and 
usage of medication in older women. The level of 
physical activity was assessed using a pedometer. 
Use of medication was assessed through medi-
cal records supplied in reports kept by the Fam-
ily Health Program, City Health Department, São 
Caetano do Sul, São Paulo State, Brazil. Regular 
use of pharmaceuticals, regardless of type of ill-
ness or treatment, was listed. Data analysis was 
performed using Poisson regression to estimate 
the prevalence ratio. The results of the study in-
dicated that, amongst the 271 eligible women, 
84.9% had been classified as active. Only 23.2% 
did not use any type of medication while 29.8% 
used three or more medications. The level of 
physical activity was inversely associated with 
the number of medications used, under both 
crude analysis and after adjustment. The study 
concluded that higher volumes of physical activ-
ity were significantly associated with lower usage 
of pharmaceuticals in women who are involved 
in a physical activity program.
Aging; Physical Activity; Drugs
Introduction
The World Health Organization (WHO) considers 
physical inactivity to be the fourth leading cause 
of mortality worldwide 1. A great amount of effort 
has been made to minimize the impact of seden-
tary lifestyles on the public health system which is 
why physical activity was included in the Global 
Strategy on Diet, Physical Activity and Health – an 
agenda released by the WHO in 2004 2 and, most 
recently, in a document published by the Ameri-
can Heart Association 3.
In Brazil, there remains little information avail-
able regarding the prevalence of physical activity 
in older individuals (60 or older) which shows the 
factors that are associated with the level of physi-
cal activity 4,5 and health conditions (i.e. presence 
or absence of disease, health perception and use 
of medication, among others) and which employs 
objective techniques to measure levels of physical 
activity.
Aging alone is a risk factor for a number of 
diseases, creating the demand for more health 
care as people grow older. Some studies suggest 
that increasing levels of physical activity among 
the population could not only postpone the de-
velopment of chronic diseases 6 but also generate 
great savings for healthcare systems 7,8. Medicine 
consumption, in general, can be an indicator of 
overall health status 9, and some studies show that 
individuals who practice low levels of physical ac-
tivity may be more likely to consume more medi-
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cation or spend more on health care, as compared 
to those individuals with higher levels of physical 
activity 10,11. A recent intervention study showed 
that the increased physical-activity levels in hy-
pertensive women resulted in a reduction of 28% 
on medical consultations, 45% on examinations 
and an additional 24.8% reduction in the use of 
medication. The savings on vasodilator medicines 
reached 63.2% 12.
The objective of this study was to analyze the 
association between physical activity and regular 
medicinal consumption in elderly women.
Methods
This study was part of a survey on the levels of 
physical activity and related health aspects in a 
sample of the population attended to by commu-
nity physical-activity programs in São Caetano 
do Sul, São Paulo State, Brazil. These programs 
are coordinated by the City Department of Health 
and have been developed in partnership with the 
Family Health Strategy (FHS) 13. The city has 15 
districts, 11 of which have a health service model 
with the FHS that covers 66% of the population.
The 11 districts serviced by the FHS develop 
community physical-activity programs with all 
activities guided by physical-education profes-
sionals. All of the community physical-activity 
programs offer similar activities in 60-minute 
classes, two days a week. The general objectives 
of said activities are the development of aero-
bic power as well as an increase and subsequent 
maintenance of muscle strength, balance and 
flexibility, all of which are consistent with the 
recommendations for physical activities 14,15. 
In each of the 11 physical-activity centers, at-
tendance is taken at the beginning of each class 
and each participant is required to maintain a 
minimum 75% attendance rate each month. 
Moreover, at the end of each class, the physical-
education professional provides guidance to the 
participants for adopting a more active lifestyle 
during everyday activities. Further details regard-
ing the program may be obtained in a previously 
published article 16.
In consideration of the low rate of male par-
ticipation in the programs, the analyses were re-
stricted to women who met the following eligibil-
ity criteria: 60 years of age or older and involved 
in physical-activity programs coordinated by the 
FHS, with an attendance rate of 75% or greater 
for classes held over the six months prior to data 
collection. The population studied included all 
individuals meeting the eligibility criteria.
For the purposes of data collection, health 
centers were visited between the months of 
March and October, 2009, with the interviews 
being conducted in advance by trained health 
professionals.
All individuals who participated in the study 
signed a consent form and met the standards 
for research involving humans. The project was 
approved by the Ethics in Research Committee 
of the Federal University of São Paulo (Univer-
sidade Federal de São Paulo – UNIFESP), under 
protocol number 0956/08, and the Municipal 
Hospital Complex in São Caetano do Sul, under 
protocol number 0125/10.
Assessment of physical-activity level
The physical-activity level was assessed through 
the number of steps taken using a Yamax Digi-
walker (model SW-200, Japan) pedometer. The 
protocol for pedometer use was proposed by 
Tudor-Locke et al. 17 and consisted of wearing the 
pedometers at the waistline (iliac crest), for seven 
consecutive days. In addition to the pedometer, 
subjects were provided with written instructions 
on its use and a seven-day diary in which to re-
cord the dates and times the device was worn, 
the time it was taken off and the total number of 
steps recorded during each day.
The average daily use was 10 hours/day. Pick-
up and delivery of the measuring instruments 
were always performed during the first lesson of 
the week.
The physical-activity cutoff points for the 
scores were based on recommendations for the 
number of steps with “insufficiently active” being 
up to 5,999 steps, “active” falling between 6,000 
and anything over 8,500 steps being considered 
“very active” 18.
Assessing medicine use
The number of medications consumed was mea-
sured by reviewing the medical records of FHS, 
prioritizing medicines prescribed on the most 
recent visit to the doctor and considering only 
the regular use of medications for treatment of 
non-communicable chronic diseases (NCDs).
Self-medication was not considered in the 
present study. The frequency of use of medicines 
and their dosages were also not explored.
Additional independent variables
The following independent variables were col-
lected: 
• Age: years, later categorized;
• Ethnicity: observed by the interviewer;
• Schooling: years of study, further categorized;
• Smoking: regular consumption of cigarettes;
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• Body mass index (BMI): weight (kg) divided by 
the square of height (meters), further categorized 
according to the criterion of normal (< 26kg/m2) 
and overweight (> 26kg/m2);
• Number of falls in the last year: self reported;
• Alcohol consumption: the usual frequency 
≥ than twice a week;
• Diagnosis of diabetes: from medical records;
• Diagnosis of hypertension: from medical re-
cords;
• Abdominal circumference: normal (< 0.80cm) 
and risk (> 0.80cm);
• Waist-hip ratio: normal (< 0.90cm) and risk 
(> 0.90cm);
• Bone fracture in the last year: self-reported;
• Sitting time: average weekly time (hours/day) 
independent of activity (occupational, leisure 
and transport).
Statistical analysis
Descriptive analysis is shown (proportions for 
categorical data and means, with standard de-
viations). Crude analyses between the level of 
physical activity and independent variables were 
conducted using the chi-square test for hetero-
geneity (categorical variables) and linear trend 
(ordinal variables). A Poisson regression 19,20 was 
used to adjust for potential confounding factors.
The final model was composed of variables 
with p < 0.20 in the adjusted analysis. The effect 
of physical activity on the use of medication was 
initially adjusted for age and ethnicity. Later, edu-
cation was included as a potential confounder. 
Finally, the following variables were added to be 
tested in the model: fracture in the last year, falling 
in the last year, alcohol intake, smoking, diabetes, 
hypertension, waist circumference, waist-hip ra-
tio and sitting time. The level of significance was 
set to p < 0.05. All tests were performed in Stata 
statistical package, version 10.0 (Stata Corp., Col-
lege Station, USA).
Results
The data analyzed were collected from the 271 
eligible women, 60 years of age or older and in-
volved in physical-activity programs coordinated 
by the FHS, with an attendance rate greater than, 
or equal to, 75% of the classes over the six months 
immediately prior to data collection. The popu-
lation studied included all individuals (100%) 
meeting the eligibility criteria. The study sample 
had a mean of 26.6 months (SD 8.4, minimum 
7.0 and maximum 46.6 months) of participation 
in physical-activity programs coordinated by the 
FHS in the city of São Caetano do Sul.
The mean age of the sample was 68.6 years 
(SD 7.1, minimum 60 and maximum 91 years), 
BMI, was 28.2kg/m2 (SD 12.2).
Table 1 presents the description of the sample 
for all variables and their association with phys-
ical-activity level. The women were mostly Cau-
casian (72.7%). The prevalence of hypertension 
was 44.7% with that of diabetes at 18.1%. A total 
of 15.1% of the women in the sample were clas-
sified as insufficiently active. Nearly one quar-
ter (23.2%) did not use any kind of medication 
while 29.9% used three or more medicines. Upon 
analyzing the associations with physical activ-
ity, women who did not consume medications, 
including those with schooling of between 0 and 
2 years, were more active (p ≤ 0.001 and 0.003, 
respectively).
Medications for cardiovascular (36.5%), ner-
vous system (13.5%), endocrine system (12.6%), 
gastrointestinal tract (18.3%), musculoskeletal 
(11.9%) and respiratory diseases (6.9%) were the 
most used.
Figure 1 demonstrates that the higher the lev-
el of physical activity, the lower the frequency of 
medicine utilization (p <0.001). The proportions 
of medicine use were 100% among insufficiently 
active individuals (< 6,000 steps per day), 88.6% 
in active individuals (6,000 to 8,500 steps per day) 
and 69.3% among very active individuals (> 8,500 
steps per day).
Figure 2 shows the relationship between the 
number of medicines used and level of physical 
activity. The proportion of individuals using four 
or more medications was higher among insuf-
ficiently active subjects (p < 0.001). High levels 
of physical activity were associated with lower 
medicinal consumption.
Table 2 presents the crude and adjusted anal-
yses of the association between physical-activity 
level and medication usage. After adjustment for 
confounders, the level of physical activity was in-
versely associated with medicinal use. The most 
active group (> 8,500 steps / day) presented a 47% 
lower prevalence when compared to sedentary 
individuals.
Discussion
To the best of our knowledge, this is the first study 
to examine this kind of association using an ob-
jective measure of physical activity and finding 
an inverse association between physical activity 
and medicinal consumption, even after control-
ling for confounders.
A Brazilian population-based study 21, with 
3,182 individuals who responded to the Inter-
national Physical Activity Questionnaire (IPAQ 
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Table 1
Description of the sample in terms of demographic and socioeconomic variables, physical activity and medicine use. São 
Caetano do Sul, São Paulo State, Brazil, 2009.
Variables n % Active % p-value
Age (years) 0.570 *; 0.973 **
60-64 90 33.21 86.7
65-74 125 46.13 82.4
≥ 75 56 20.66 87.5
Ethnicity 0.058 *
Caucasian 191 70.48 82.20
Non-Caucasian 80 29.52 91.25
Schooling (years) 0.003 *; 0.360 **
0-2 105 38.8 91.43
3-4 90 33.2 74.44
5 + 76 28.04 88.16
Bone fracture 0.152 *
Yes 240 88.56 83.75
No 31 11.44 93.55
Falls in the last year 0.454 *
Yes 171 63.10 83.63
No 100 36.90 87.00
Alcohol intake 0.224 *
Never 125 46.13 80.80
Former 68 25.09 88.24
Current 78 28.78 88.46
Smoking 0.601 *
Yes 232 85.61 85.3
No 39 14.39 82.1
Medicine use < 0.001 *
Yes 208 76.75 100.0
No 63 23.25 80.29
Diabetes 0.856 *
Yes 222 81.92 84.68
No 49 18.08 85.71
Hypertension 0.560 *
Yes 150 55.35 86.00
No 121 44.65 83.47
Abdominal circumference (cm) 0.807 *
< 80 77 28.41 85.71
≥ 80 194 71.59 84.54
BMI (kg/m2) 0.479 *
< 26 106 39.11 86.79
≥ 26 165 60.89 83.64
Waist-hip ratio (cm) 0.653 *
< 0.90 101 37.27 86.14
≥ 0.90 170 62.73 84.12
Sitting time 0.124 *; 0.125 **
1st Tertile 106 39.11 86.79
2nd Tertile 88 32.47 88.64
3rd Tertile 77 28.41 77.92
Total 271 100.00 84.87
BMI: body mass index.
* Chi-square test for heterogeneity;
** Chi-square test for linear trend.
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Figure 1
Prevalence of medicine use according to the number of daily steps in older women. São Caetano do Sul, São Paulo State, Brazil, 2009.
Figure 2
Association between physical activity level and number of medicines used in women. São Caetano do Sul, São Paulo State, 
Brazil, 2009.
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after adjusting for confounders. The significant 
association found in this study cannot be under-
stood as a possible residual confounding. The 
fact that the adjusted analysis did not provide 
results differing from those obtained in the crude 
analysis minimizes the likelihood of residual 
confounding.
In the multinational study Monitoring of 
Trends and Determinants in Cardiovascular Dis-
ease project (MONICA) 22, the risk of developing 
hypertension decreased linearly as the level of 
leisure-time physical activity increased, among 
both men and women. Men with high leisure-
time physical activity had a, statistically, signifi-
cantly reduced risk of hypertension, even after 
adjustment for age, education, smoking, alcohol 
intake and body mass index [hazard ratio (HR) 
0.79; 95% confidence interval (CI) 0.63 to 0.99].
The reduction in blood pressure induced by 
the chronic effect of physical activity (hypoten-
sive effect) has been attributed to lower systemic 
vascular resistance 23 caused by reduced sym-
pathetic activity. Other hypotheses suggest that 
the reduction of plasma rennin activity, reduced 
concentrations of catecholamines 24, urinary so-
dium excretion and increased insulin sensitiv-
ity 25 may be influenced by the engagement in 
regular physical activity. In fact, physical training 
has been shown to trigger an improvement in the 
production of endothelium-dependent vasodila-
tor substances 26,27.
Among previously published studies, one of 
the limitations is the fact that self report was used 
to measure medicinal consumption 28,29,30, thus 
becoming more likely to be affected by recall bias 
among older people 31. In the present study, this 
problem was not present as medical records were 
used.
Another strong point of this study is that the 
assessment of physical activity was carried out 
by an objective instrument. In the elderly, these 
questionnaires are subject to recall errors which 
interfere with the estimated duration of activities 
during the week 32. Furthermore, as was the case 
in this study, when evaluating overall physical 
activity, the overestimation of data on physical 
activity in domestic and work environments is a 
problem 33.
Some limitations in this study must be con-
sidered. First, the cross-sectional nature of data 
collecting does not allow us to establish causal 
relationships between physical activity and me-
dicinal consumption. On one hand, we expect 
that individuals who become active shall im-
prove overall health and reduce medicine con-
sumption. The fact is that subjects with a history 
of healthy habits such as regular physical activity, 
healthy eating and lower alcohol intake can enjoy 
additional benefits by slowing the rise of chronic 
diseases and thus decreasing the chances of high 
medication consumption 34.
Family income data were missing (family 
gross income, in Reais) for 171 elderly (63.1%) 
in the sample. However, an exploratory analysis 
was carried out among individuals who informed 
their income and we did not find evidence of as-
sociation with physical activity or medication 
use. Thus, it was excluded from the final model.
In relation to the sample, it is worth noting 
that all women were engaged in physical activity 
sponsored by the FHS. Thus, while extrapolation 
of results to the general population should be 
performed with caution, the findings show that 
even for those who are active, physical-activity 
levels may represent an important impact on 
medicine consumption.
Table 2
Multivariable analyses of the association between medicine use and physical activity level in women physically independent. São Caetano do Sul, São Paulo 
State, Brazil, 2009.
Variables PR crude analysis 
(95%CI)
p-value PR adjusted (95%CI) * p-value
Physical activity level (steps/day) < 0.001 **; < 0.001 *** < 0.001 **; < 0.001 ***
< 6,000 1.00 1.00
6,001-8,500 0.81 (0.59-1.10) 0.87 (0.69-1.09)
> 8,500 0.45 (0.34–0.59) 0.53 (0.43-0.65)
PR: prevalence ratio; 95%CI: 95% confi dence interval.
* Adjusted for age, ethnicity, education, fracture in the last year, falling last year, alcohol intake, smoking, diabetes, hypertension, waist circumference, waist-hip 
ratio, BMI, sitting time;
** Wald test for heterogeneity;
*** Wald test for linear trend.
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Conclusion
Higher levels of physical activity were signifi-
cantly associated with lower use of medication in 
women engaged in a physical-activity program 
and public healthcare users. These findings sug-
gest that involvement in physical activity can help 
to reduce medicinal use among elderly women 
who are functionally independent.
Resumo
O objetivo deste estudo foi avaliar a associação en-
tre o nível de atividade física e uso de medicamentos 
em mulheres com 60 anos de idade ou mais. O nível 
de atividade física foi avaliado utilizando pedômetro. 
O consumo de medicamento foi avaliado mediante o 
prontuário de cadastro da Estratégia Saúde da Famí-
lia em São Caetano do Sul, São Paulo, Brasil. Foram 
registrados os medicamentos de uso regular indepen-
dente do tipo da doença ou do tratamento. Foi reali-
zada análise de regressão de Poisson para estimar a 
razão de prevalências. Das 271 mulheres elegíveis, 
84,9% foram classificadas como ativas. Apenas 23,2% 
não utilizam nenhum tipo de medicamento, enquanto 
29,8% utilizaram três ou mais medicamentos. O nível 
de atividade física foi inversamente associado com o 
número de medicamentos utilizados tanto na análise 
bruta como na ajustada. Maiores volumes de ativida-
de física associaram-se significativamente com menor 
consumo de medicamentos em mulheres envolvidas 
em um programa de atividade física. 
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